Oncology & Cancer

Researchers discover method to 'turn off' mutated melanoma

Melanoma is the deadliest form of skin cancer and notorious for its resistance to conventional chemotherapy. Approximately 25 percent of melanoma is driven by oncogenic mutations in the NRAS gene, making it a very attractive ...

Oncology & Cancer

ATA issues guidelines for managing anaplastic thyroid cancer

(HealthDay)—In new guidelines issued by the American Thyroid Association and published in the March issue of Thyroid, recommendations are presented for the diagnosis, evaluation, and treatment of anaplastic thyroid cancer ...

Pediatrics

Pharmacological therapy to fight a rare pediatric disease

Scientists from the University of Granada (UGR) have developed a new pharmacological therapy using a molecule that presents similarities with one of the precursors of coenzyme Q10 (CoQ10). The therapy is effective against ...

page 5 from 9